Elevating musculoskeletal health through targeted delivery
We’re translating insights in bone biology into targeted therapies that protect and rebuild bone—without shutting down the body’s natural bone remodeling.
Osteoclast-Activated Skeletal Intervention System
We’re building OASIS, a targeted small-molecule platform for bone health. The idea is simple: concentrate therapy where bone loss is actively happening and preserve the body’s natural remodeling.
What makes OASIS™ different
- Targeted where it matters: Designed to limit drug activity to sites of active bone loss.
- Remodeling-aware: Aims to reduce fracture risk while preserving healthy turnover.
- Built for translation: Biomarker and imaging-friendly development path from day one.
Why this is exciting for builders
- Greenfield chemistry + biology problems with real clinical endpoints.
- A platform mindset—one core architecture, multiple indications.
- Small, fast team; your work moves the science (and company) forward immediately.
Careers
Join us to rebuild skeletal resilience. We value scientific rigor, clarity, and patient impact—high ownership, low ego, fast learning loops.
Contact Us
Have questions or want to learn more? Fill out the form below or email us at info@skeletalis.bio.